What is the main business of Sincofarm?

The main business activity of Sincofarm focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 18, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Nałęczowska 26, 20-701 Lublin.

Who is on the management board?

The management board consists of: Piotr Jan Kaczmarczyk (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

In 2024, the company generated total revenue of $407,151, representing a decrease of 86.5% compared to 2023.

No, the company recorded a net loss of $194,814 in 2024.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $216,406 in 2024, representing 47% of all operating expenses.

Sincofarmsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-05-18

Share capital

5,000.00 PLN

Activity description

Sincofarm is a pharmaceutical wholesaler based in Lublin, distributing prescription and over-the-counter medicines, medical devices and materials, medical equipment, consumables and packaging across Poland. It serves pharmacies, medical facilities and hospitals, with receiving, storage, order picking and transport carried out in facilities compliant with the requirements of the Chief Pharmaceutical Inspectorate.

Registered address

ul. Nałęczowska 26, 20-701 Lublin, Poland

Website

sincofarm.pl

Opening hours

Tuesday: 8:00–14:00
Thursday: 8:00–14:00

Phone

Electronic delivery address

AE:PL-24919-40811-GRTGH-19

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 2 of 3 financial statements were filed late (the longest delay 283 days for 2024).

2025not filed
202424/04/2026
202309/07/2024
202217/07/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 407.15kMedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD -194.81kMedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 461.45kMedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 4.54mMedianUSD 608.93kAverageUSD 11.85m

Industry

Wholesale of pharmaceutical goods (46.46.Z)Primary
Wholesale on a fee or contract basis (46.1)
Non-specialised wholesale trade (46.90)

Offer

Prescription medicines
Over-the-counter medicines
Medical devices
Medical supplies
Pharmaceutical packaging
Pharmaceutical deliveries

Website technology

Website

WordPress

Analytics and marketing

Google Analytics

Authorized Representatives

Piotr Jan Kaczmarczyk – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Level Up Ventures P.S.A.	100	$1,350.62	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-07-01.

ING Bank Śląski
19 1050 1953 1000 0090 8165 2183
ING Bank Śląski
94 1050 1953 1000 0090 8165 2191
Erste Bank Polska
54 1090 2590 0000 0001 6322 6357

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o.	$600,815,720.02	slawex.com.pl
LubfarmS.A.	$123,208,945.21	lubfarm.pl
Camedica Paweł Harasimiuksp. k.	$18,691,613.15	camedica.pl
Medcomplexsp. z o.o.	$5,193,830.09	medcomplex.pl
Przedsiębiorstwo Zaopatrzenia Lecznictwa Cezal Lublinsp. z o.o.	$4,277,670.93	cezal.lublin.pl
Bio-Novumsp. z o.o.	$3,459,663.10	bio-novum.com
Myderm Laboratoriessp. z o.o.	$177,750.48	myderm.com.pl
GROW Pharmasp. z o.o.	$15,020.86	growpharma.pl
PetnovellS.A.	$0.00	petnovell.pl
Dental Łukasiksp. j.	–	dental.lublin.pl